References
- Schiessler H, Hochstrasser K, Ohlsson K. Neutral Proteases and Human Polymorphonuclear Leukocytes, K Hareman, A Janoff. Urban & Schwarzenberg, Baltimore 1978; 195–207
- Ohlsson M, Rosengren M, Tegner H, Ohlsson K. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe-Seyler's Z Physiol Chem 1983; 364: 1323–8
- Ohlsson M, Fryksmark U, Polling Å, Tegner H, Ohlsson K. Localization of antilcukoprotcase in the parotid and submandibular salivary glands. Acta Otolaryngol (Stockh) 1984; 98: 147–51
- Thompson R C, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci 1986; 83: 6692–6
- Ohlsson K, Tegner H, Åkesson U. Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion. Hoppe-Seyler's Z Physiol Chem 1977; 358: 583–9
- Klassen E C, Kramps J A. The N-terminal sequence of antileukoproteasc isolated from bronchial secretion. Biochem Biophvs Res Commun 1985; 128: 285–9
- Smith C E, Johnson P A. Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases. Biochem J 1985; 225: 463–72
- Seemüller U, Arnhold M, Fritz H, Wiedenmann K, Machleidt W, Heinzel R, Appelhans H, Gassen H-G, Lottspeich F. The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I antileukoproteasc). FEB. S 1986; 199: 43–8
- Stetler G, Brewer M T, Thompson R C. Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Research 1986; 14: 7883–96
- Fryksmark U, Prellner T, Tegner H, Ohlsson K. Studies on the role of antileukoproteasc in respiratory tract diseases. Eur J Respir Dis 1984; 65: 201–20
- Egbring R, Schmidt W, Fuchs G, Havemann K. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood 1977; 49: 219–31
- Aasen A O, Ohlsson K. Release of granulocyte elastase in lethal canine endotoxin shock. Hoppe-Seyler's Z Physiol Chem 1978; 359: 683–90
- Jochum M, Witte J, Schiessler H, Selbmann H K, Ruckdeschl G, Fritz H. Clotting and other plasma factors in experimental endotoxemia: inhibition of degredation by exoenous proteinase inhibitors. Eur Surg Res 1981; 13: 152–68
- Ohlsson K. Collagenase and elastase release during peritonitis are complexcd by plasma protease inhibitors. Surgery 1976; 79: 652–7
- Henriksson P, Nilsson I M, Ohlsson K, Stenberg P. Granulocyte elastase activation and degradation of factor XIII. Thromb Res 1980; 18: 343–51
- Ohlsson K. Neutral leucocyte proteases and elastase inhibited by plasma α1antitrypsin. Scand J Clin Lab Invest 1971; 28: 251–3
- Ohlsson K, Olsson I. Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest 1974; 34: 349–55
- Gauthier F, Fryksmark U, Ohlsson K, Bieth J G. Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. Biochim Biophys Acta 1982; 700: 178–83
- Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte clastascs. Eur J Biochem 1974; 42: 519–27
- Laurell C-B. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29(124)21–37, Suppl 124
- Brandslund I, Teisner B, Hyltoft Petersen P, Svehag S-E. Development and clinical application of electroimmunoassays for the direct quantification of complement C3 split products C3c and C3d. Scand J Clin Lab Invest 1984; 44: 57–73, Suppl. 168
- Ganrot P O. Crossed immunoelectrophoresis. Scand J Clin Lab Invest 1972; 29(124)39–47, Suppl. 124
- Bieth J, Spiess B, Wermuth C E. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med 1974; II: 350–7
- Johansson B, Thorell J I. Enzymatic iodisation of polypeptides with 125I to high specific activity. Biochim Biophys Acta 1971; 251: 363–9
- Gustavsson E-L, Ohlsson K, Olsson A-S. Interaction between human pancreatic elastase and plasma protease inhibitors. Hoppe-Seyler's Z Physiol Chem 1980; 361: 169–76
- Seiz R, Wolf M, Egbring R, Radtke K-P, Ziesen-Feld A, Pittner P, Havemann K. Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections. Blood 1987; 120: 544–55
- Fryksmark U, Ohlsson K, Rosengren M, Tegner H. A radioimmunoassay for measurement and characterization of human antileukoproteasc in serum. Hoppe-Seyler's Z Physiol Chem 1981; 362: 1275–7
- Bruch M, Bieth J G. Influence of elastin on the inhibition of leucocyte elastase by α1-proteinase inhibitor and bronchial inhibitor. Biochem J 1986; 238: 269–73
- Lasson Å, Ohlsson K. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum. Biochim Biophys Acta 1982; 709: 227–33
- Lasson Å, Dittmann B, Ohlsson K. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man. Hoppe-Seyler's Z Physiol Chem 1983; 364: 1315–22